Skip to content

PRobiotics for EVEry Newborn Trial

PREVENT: PRobiotics for EVEry Newborn vs Treatment-as-Needed Comparative Effectiveness Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04537494
Acronym
PREVENT
Enrollment
32
Registered
2020-09-03
Start date
2021-12-01
Completion date
2023-09-08
Last updated
2025-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colic, Infantile

Keywords

Colic, Probiotic, Infant

Brief summary

The aim of the study is to compare prevention (oral supplementation with the probiotic L. reuteri administered to every newborn within the first week of life for 12 weeks) with treatment-as-needed (supplementation with the probiotic L. reuteri after randomization, to infants who develop excessive cry/fuss up to 12 weeks of age). This is a single site pilot study to assess feasibility for a full trial.

Detailed description

One in five infants experience colic, defined as recurrent and prolonged episodes of crying and fussing with no obvious cause in healthy infants less than 5 months of age. There is evidence to support the role of the probiotic L. reuteri for treatment of colic in breastfed babies and for prevention of colic. However, these two options (prevention vs treatment-as-needed) have not been previously compared head-to-head. The study aims determine if oral supplementation with the probiotic L. reuteri administered to every newborn within the first week of life for 12 weeks (prevention) is superior to treatment-as-needed, as measured by daily cry/fuss duration at 6 and 12 weeks of age.

Interventions

DIETARY_SUPPLEMENTL. reuteri

Probiotic

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

For the 2 Randomized arms, all parties were masked. For the 2 Parent Preference arms, all parties were unmasked (open label)

Eligibility

Sex/Gender
ALL
Age
1 Days to 7 Days
Healthy volunteers
Yes

Inclusion criteria

1. 1 to 7 days of age 2. term (37 to 41 weeks) 3. breast or formula fed 4. birth weight \> 2500 grams 5. parental consent

Exclusion criteria

1. congenital or other medical disorders 2. parents unable to communicate in English or French

Design outcomes

Primary

MeasureTime frameDescription
Combined infant daily cry/fuss durationBaselineThe primary outcome will be infant daily cry/fuss duration (combined cry and fuss in minutes) measured using the modified Baby's Day Diary over a 48 hour period.

Secondary

MeasureTime frameDescription
Infant daily fuss durationBaseline, 6 and 12 weeks of ageDaily fuss duration will be examined separately
Infant colic12 weeksDaily cry/fuss of at least 180 minutes
Infant daily sleep durationBaselineSleep duration will be measured objectively using actigraphy worn around the infant's ankle over a sock.
Parent (female and male) mental healthBaselineMental health will be measured using the Edinburgh Postnatal Depression Scale, a validated 10-item screening questionnaire. Scores range between 0 and 30 and higher scores mean worse outcome.
Parent (female and male) fatigueBaselineFatigue will be measured using a validated Fatigue Visual Analogue Scale. Scores will range between 0 and 180, higher score means worse outcome
Infant daily cry durationBaselineDaily cry duration will be examined separately
Adverse effects - digestive upset8 weeksNumber of participants with occurrences of digestive upset (e.g., diarrhea), in the Baby's Day Diary
Adverse effects - growth/length8 weeksInfant growth (length) will be measured at scheduled health supervision visits
Adverse effects - growth/weight8 weeksInfant growth (weight) will be measured at scheduled health supervision visits
Adverse effects - growth/head circumference8 weeksInfant growth (head circumference) will be measured at scheduled health supervision visits
Health services utilizationBaselineFrequency of assessments
Gut microbial composition, diversity and functionBaselineMicrobial composition, diversity and function will be measured in infant fecal samples.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026